SOPHiA GENETICS (SOPH) Net Cash Flow (2020 - 2025)
SOPHiA GENETICS's Net Cash Flow history spans 6 years, with the latest figure at -$12.0 million for Q4 2025.
- On a quarterly basis, Net Cash Flow rose 7.13% to -$12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.2 million, a 63.51% increase, with the full-year FY2025 number at -$14.2 million, up 63.51% from a year prior.
- Net Cash Flow hit -$12.0 million in Q4 2025 for SOPHiA GENETICS, up from -$13.3 million in the prior quarter.
- Over the last five years, Net Cash Flow for SOPH hit a ceiling of $168.8 million in Q3 2021 and a floor of -$20.8 million in Q3 2022.
- Historically, Net Cash Flow has averaged -$156050.0 across 5 years, with a median of -$12.2 million in 2021.
- Biggest five-year swings in Net Cash Flow: tumbled 1915.5% in 2023 and later surged 1596.8% in 2025.
- Tracing SOPH's Net Cash Flow over 5 years: stood at -$17.2 million in 2021, then soared by 103.42% to $587000.0 in 2022, then tumbled by 1915.5% to -$10.7 million in 2023, then dropped by 21.54% to -$13.0 million in 2024, then grew by 7.13% to -$12.0 million in 2025.
- Business Quant data shows Net Cash Flow for SOPH at -$12.0 million in Q4 2025, -$13.3 million in Q3 2025, and $23.9 million in Q2 2025.